(Reuters) -Canada's health regulator has approved Novo Nordisk's diabetes drug, Ozempic, for reducing the risk of kidney ...

Diabetic medicine Ozempic now approved by Health Canada to reduce the risk of further kidney decline among patients with Type ...

Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes. Between ...

Canada's health regulator has approved Novo Nordisk's diabetes drug, Ozempic, to reduce the risk of kidney failure and ...

Health Canada has approved Ozempic in an effort to help reduce the risk of kidney decline for patients living with Type 2 ...

According to Google Canada, Quebec City is the first municipality in the country to partner with the web giant's Green Light ...

The law gives Quebec's labour minister the power to end a labour dispute by imposing arbitration when the strike or lockout is deemed likely to cause serious harm to the public.

Danish drugmaker Novo Nordisk (NVO) on Tuesday said that its blockbuster drug Ozempic is now approved in Canada to reduce the risk of kidney function decline, end-stage kidney disease, and ...

The price of crude oil dropped to $62.46 a barrel Monday morning, part of a downward trend that some analysts say could ...

Tropical Storm Erin is expected to strengthen into a powerful Category 4 hurricane with sustained winds of up to 156 mph as ...